Aronoff A, Gault M H, Huang S N, Lal S, Wu K T, Moinuddin M D, Spence L, MacLean L D
Can Med Assoc J. 1973 Jan 6;108(1):43-50.
Over a seven-year period 18 of 125 patients who underwent renal transplantation developed hepatitis. Acute hepatic necrosis occurred in two, chronic aggressive hepatitis progressing to posthepatitic cirrhosis in eight, chronic persistent hepatitis in five, acute hepatitis with recovery in two and cholestatic hepatitis in one. Hepatic failure was the cause of death in four and a major contributing factor in three. Fifteen of the 18 were of blood Group A. After renal transplantation Australia antigen (Au) was present in the blood of 12 of the 15 patients with hepatitis who were tested and in one of 38 patients without clinical evidence of liver disease. Once present, Au persisted in all patients but one. Particles measuring 210 to 250 A, characteristic of Au, were seen in liver cells by electronmicroscopy in nine of the 10 patients examined who had hepatitis with Australia antigenemia, but they were not seen in the two patients studied with Au-negative hepatitis.
在七年时间里,125例接受肾移植的患者中有18例发生了肝炎。其中2例出现急性肝坏死,8例慢性侵袭性肝炎进展为肝炎后肝硬化,5例为慢性持续性肝炎,2例急性肝炎恢复,1例为胆汁淤积性肝炎。肝功能衰竭是4例患者的死亡原因,也是3例患者的主要促成因素。18例患者中有15例为A型血。在接受检测的15例患肝炎的肾移植患者中,有12例血液中存在澳大利亚抗原(Au),而在38例无肝病临床证据的患者中有1例存在该抗原。一旦出现,除1例患者外,Au在所有患者体内持续存在。在接受检查的10例患肝炎且有澳大利亚抗原血症的患者中,有9例通过电子显微镜在肝细胞中发现了大小为210至250埃、具有Au特征的颗粒,但在2例患非澳大利亚抗原血症肝炎的患者中未发现此类颗粒。